Elon Musk's initial closeness to President Trump in early 2025 has soured, with Trump's policies now negatively impacting ...

Tesla, Inc.'s Q3 2025 earnings beat on revenue but missed on profit; declining margins, lost credits, and high valuation ...

If you have been eyeing Intel’s stock and wondering whether it has more room to run, you are certainly not alone. Over the ...

We’re meant to appreciate the little things in life, but it gets very challenging to do so when they mostly consist of mildly ...

Thinking about what to do with your Travere Therapeutics stock? You are not alone. The past few months have been busy for this biotech name, giving investors new reasons to pay attention. Maybe you ...